Trump unveils deals to lower US weight-loss drug prices

In a move to reduce weight-loss drug prices, President Trump announced agreements with pharmaceutical companies Eli Lilly and Novo Nordisk. The deals will make drugs like Wegovy and Zepbound more affordable, with costs ranging from $245 to $350 per month. The agreements aim to expand access to these medications through Medicare and Medicaid, providing lower prices for consumers. Additionally, Eli Lilly will be exempt from tariffs for three years as part of the deal.